Esophageal cancer gene test for treatment response
Part of Cancer, Digestive system clinical trials.
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old and have esophageal cancer that was confirmed by a biopsy.
- Your cancer has not spread to other organs like the liver or lungs, as shown by recent scans.
- You have not had any other cancer before (except for some skin cancers).
- You have not had surgery, chemotherapy, radiation, or immunotherapy for this cancer yet.
- You are expected to live at least 6 months, based on your general health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
This study tests a combination of chemotherapy, immunotherapy, and radiation for esophageal cancer that cannot be surgically removed. It also uses a simple blood test (ctDNA) to monitor your cancer's response throughout treatment.
This trial uses a blood test to find tiny bits of tumor DNA after surgery. If the test is positive, you may receive additional therapy to lower the risk of cancer coming back.
This trial tests whether adjusting treatment based on a blood test (ctDNA) after standard chemoradiation can improve outcomes for patients with advanced esophageal squamous cell carcinoma. It aims to find a more personalized approach to prevent cancer recurrence.
This trial looks at how gene changes called methylation can help doctors track how well treatment is working for gastric cancer. If you are newly diagnosed and have not had surgery or chemotherapy yet, you may be able to join.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.